Article -> Article Details
Title | Anti-ageing Drugs Market Outlook, Trends, Segments, Analysis and Forecast – 2030 |
---|---|
Category | Fitness Health --> Health Articles |
Meta Keywords | Anti-ageing Drugs Market, Anti-ageing Drugs Market Size, Anti-ageing Drugs Market Industry, Global Anti-ageing Drugs Market, Anti-ageing Drugs Market Research, |
Owner | Vaibhav |
Description | |
Anti-ageing
Drugs Market Share is expected grow USD 90.20 Billion at a CAGR 7.10%
during the forecast 2022 - 2030 Anti-Ageing
drugs are mixture of biochemical process and advanced medicines, it is
basically used for treatment of age related disorders and for those peoples who
are concern for their aesthetic looks. Products that ability reversal of aging
signs that seem on the skin are consider as anti-aging products. In recent
market, anti-aging products are in demand owing to the growing usage of
moisturizer-based cosmeceutical products used for skin care. Increasing income
with changing life style are helping the anti-ageing drug market to drive in
positive ladder. Additionally, rising in aging population fueling the growth of
Anti-ageing Drugs Market. It is not limited to the skin problem, it is for the
entire body. Furthermore, many medical and start-up companies are injecting capital
for better results. According to the World Health Organization (WHO), the
proportion of the world's population over 60 years between 2015 and 2050 will
nearly double from 12% to 22%. Major Key
Players: Allergan, plc (Ireland), GlaxoSmithKline plc (U.K), Johnson
& Johnson (U.S.), Nu Skin (U.S.), Novartis AG (Switzerland), RGP Life
Sciences (India), The Estée Lauder Companies Inc. (U.S.), Bayer Pharma AG
(Germany), L'Oréal S.A. (France), Elysium Health Inc. (U.S.), BioTime, Inc.
(U.S.), Elysium Health Inc (U.S.) are some of the Key
Anti-ageing Drugs Market Players, globally. Market Overview The global anti-ageing drugs market is showing the significant
growth; mainly due to increase in ageing population, growing demand for
anti-aging drugs, and influence of media and fashion industry. As per World
Health Organization (WHO) estimates, by 2020, the number of people aged 60
years and older will outnumber children younger than 5 years and by 2050, 80%
of older people will be living in low- and middle-income countries. Companies are showing much interest toward the anti-aging
drugs market, as they feels there are huge opportunity and gap between the
market demand and supply of effective treatments. Thus, companies are showing
more interest in merger and acquisition activities for introducing best drugs
that meet the requirement of market. The development has been made by Johnson
& Johnson in 2016, when they announced the acquisition of NeoStrata
Company, Inc., for getting the global leadership and deliver advanced skin care
drugs to consumers around the world. Also, in 2015, The Estée Lauder Companies
Inc. announced the completion of its acquisition of GLAMGLOW. These acquisition
will leads to innovation in better way and help them to compete there
competitor with more effective manner. Johnson & Johnson try to feel the
gap along with market players such as GlaxoSmithKline plc (U.K), Johnson &
Johnson, Nu Skin, Novartis AG, RGP Life Sciences, The Estée Lauder Companies
Inc., Bayer Pharma AG, L'Oréal S.A., Elysium Health Inc. Regional
Analysis Global Anti-ageing Drugs Market
Outlook, based on region, has been divided
into Europe, the Americas, Asia-Pacific, and Middle East & Africa. The market of anti-ageing drugs
is much higher in the Americas region. There are several factors for tremendous
growth of the anti aging products
market in this region such as high disposable income, increasing awareness of
aesthetic looks, and increasing awareness about ageing signs. According to U.S.
Census Bureau, Around 83.1 million are millennial present in United Nation
which represent more than one quarter of the national population. Europe is also consider huge
market for anti-aging drugs players, owing to present of huge ageing
population. Moreover, the population within the reason are more aware about the
healthcare in comparison to other region like Asia Pacific and The Middle East
and Africa. Asia Pacific and the Middle East
and Africa region are considering the big opportunity for the market players
owing to changing life style. Whereas country like India and china of Asia
Pacific region are considering fastest growing region. These countries are open
to adopt new drugs from developed countries in order to improve the quality of
life for their citizen. In 2014, it is expected that anti-ageing drugs market
growth in Japan would be higher in compared to other Asian countries. Japan is
well developed country and have well established healthcare system and
technology, whereas developing countries are still focusing on new technology
which lead to increase in the demand for various anti-ageing drugs. Most of the
countries from these region such as India and China are investing more into
research and development activity for introducing better drugs at nominal
price. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help to answer
all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 |